ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Srv560
|
10K |
4.8M |
51 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
10K
|
4.8M
|
51
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT-DX1 engineering update
|
|
Srv560
|
176 |
60K |
1 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
176
|
60K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Srv560
|
956 |
301K |
4 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
956
|
301K
|
4
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Srv560
|
10K |
4.8M |
7 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
10K
|
4.8M
|
7
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Srv560
|
10K |
4.8M |
3 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
10K
|
4.8M
|
3
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Srv560
|
10K |
4.8M |
27 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
10K
|
4.8M
|
27
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Srv560
|
10K |
4.8M |
4 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
10K
|
4.8M
|
4
|
|
ASX - By Stock
|
PAB |
Re:
Time for Campbell to resign
|
|
Srv560
|
23 |
7.4K |
4 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
23
|
7.4K
|
4
|
|
ASX - By Stock
|
PAB |
Re:
Time for Campbell to resign
|
|
Srv560
|
23 |
7.4K |
0 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
23
|
7.4K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT-DX1 engineering update
|
|
Srv560
|
176 |
60K |
3 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
176
|
60K
|
3
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Srv560
|
10K |
4.8M |
24 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
10K
|
4.8M
|
24
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT-DX1 engineering update
|
|
Srv560
|
176 |
60K |
4 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
176
|
60K
|
4
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Application for quotation of securities - BRN
|
|
Srv560
|
10 |
5.7K |
2 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
10
|
5.7K
|
2
|
|
Charts
|
BRN |
Re:
Chart
|
|
Srv560
|
20K |
8.2M |
1 |
16/01/22 |
16/01/22 |
Charts
|
20K
|
8.2M
|
1
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Srv560
|
10K |
4.8M |
0 |
16/01/22 |
16/01/22 |
ASX - By Stock
|
10K
|
4.8M
|
0
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Srv560
|
10K |
4.8M |
4 |
16/01/22 |
16/01/22 |
ASX - By Stock
|
10K
|
4.8M
|
4
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Srv560
|
10K |
4.8M |
7 |
16/01/22 |
16/01/22 |
ASX - By Stock
|
10K
|
4.8M
|
7
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Srv560
|
10K |
4.8M |
8 |
16/01/22 |
16/01/22 |
ASX - By Stock
|
10K
|
4.8M
|
8
|
|
ASX - By Stock
|
BRN |
Re:
<BNR> Who is he?
|
|
Srv560
|
54 |
11K |
7 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
54
|
11K
|
7
|
|
Charts
|
BRN |
Re:
Chart
|
|
Srv560
|
20K |
8.2M |
11 |
13/01/22 |
13/01/22 |
Charts
|
20K
|
8.2M
|
11
|
|
ASX - By Stock
|
BRN |
Re:
BRN SHARE PRICE PREDICTION BY CHRISTMAS 2022
|
|
Srv560
|
298 |
186K |
39 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
298
|
186K
|
39
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Change of Director's Interest Notices x2
|
|
Srv560
|
204 |
66K |
1 |
30/12/21 |
30/12/21 |
ASX - By Stock
|
204
|
66K
|
1
|
|
ASX - By Stock
|
NXL |
Re:
not selling
|
|
Srv560
|
344 |
94K |
2 |
29/12/21 |
29/12/21 |
ASX - By Stock
|
344
|
94K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Change of Director's Interest Notices x2
|
|
Srv560
|
204 |
66K |
3 |
29/12/21 |
29/12/21 |
ASX - By Stock
|
204
|
66K
|
3
|
|
ASX - By Stock
|
BRN |
Re:
2021 BRN Discussion
|
|
Srv560
|
33K |
11M |
2 |
29/12/21 |
29/12/21 |
ASX - By Stock
|
33K
|
11M
|
2
|
|
ASX - By Stock
|
PAB |
Re:
PAB morning auction
|
|
Srv560
|
21 |
6.0K |
8 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
21
|
6.0K
|
8
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Becoming a substantial holder from MQG
|
|
Srv560
|
83 |
28K |
1 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
83
|
28K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Becoming a substantial holder from MQG
|
|
Srv560
|
83 |
28K |
1 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
83
|
28K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Appointment of Sean Hehir as CEO
|
|
Srv560
|
670 |
217K |
2 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
670
|
217K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Market Update - PAT-DX1 Clinical Trial Preparation
|
|
Srv560
|
244 |
77K |
0 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
244
|
77K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Market Update - PAT-DX1 Clinical Trial Preparation
|
|
Srv560
|
244 |
77K |
10 |
22/08/21 |
22/08/21 |
ASX - By Stock
|
244
|
77K
|
10
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Market Update - PAT-DX1 Clinical Trial Preparation
|
|
Srv560
|
244 |
77K |
4 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
244
|
77K
|
4
|
|